Select Medical (NYSE:SEM) Receives Buy Rating from Benchmark

Select Medical (NYSE:SEM - Get Free Report)'s stock had its "buy" rating reissued by investment analysts at Benchmark in a research report issued on Friday, Benzinga reports. They currently have a $48.00 price target on the health services provider's stock. Benchmark's price target suggests a potential upside of 33.52% from the stock's previous close.

Separately, Bank of America began coverage on shares of Select Medical in a report on Tuesday, August 20th. They set a "buy" rating and a $42.00 price target for the company. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $39.00.

Select Medical Stock Up 12.1 %

Shares of NYSE SEM traded up $3.87 during mid-day trading on Friday, hitting $35.95. The company had a trading volume of 1,545,139 shares, compared to its average volume of 602,303. The company has a market capitalization of $4.67 billion, a PE ratio of 17.38, a price-to-earnings-growth ratio of 2.03 and a beta of 1.41. The business's 50-day simple moving average is $34.25 and its 200 day simple moving average is $33.91. Select Medical has a 1-year low of $21.28 and a 1-year high of $40.50. The company has a debt-to-equity ratio of 2.11, a current ratio of 1.09 and a quick ratio of 1.09.

Select Medical (NYSE:SEM - Get Free Report) last announced its quarterly earnings data on Thursday, August 1st. The health services provider reported $0.60 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.61 by ($0.01). The company had revenue of $1.76 billion during the quarter, compared to analysts' expectations of $1.74 billion. Select Medical had a net margin of 3.91% and a return on equity of 17.50%. The business's quarterly revenue was up 5.1% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.61 EPS. On average, analysts predict that Select Medical will post 2.03 earnings per share for the current year.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of the stock. Financial Strategies Group Inc. boosted its stake in Select Medical by 22.1% in the third quarter. Financial Strategies Group Inc. now owns 10,709 shares of the health services provider's stock valued at $363,000 after acquiring an additional 1,938 shares in the last quarter. Principal Financial Group Inc. lifted its holdings in shares of Select Medical by 6.7% in the 3rd quarter. Principal Financial Group Inc. now owns 2,357,823 shares of the health services provider's stock valued at $82,208,000 after purchasing an additional 147,032 shares during the last quarter. EMC Capital Management boosted its position in shares of Select Medical by 63.4% in the 3rd quarter. EMC Capital Management now owns 12,536 shares of the health services provider's stock valued at $437,000 after purchasing an additional 4,862 shares during the period. Sippican Capital Advisors grew its stake in Select Medical by 30.9% during the 3rd quarter. Sippican Capital Advisors now owns 12,442 shares of the health services provider's stock worth $434,000 after buying an additional 2,937 shares during the last quarter. Finally, Mount Yale Investment Advisors LLC acquired a new position in Select Medical during the third quarter worth approximately $193,000. Institutional investors and hedge funds own 89.48% of the company's stock.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.